Endocardial (Watchman) vs epicardial (Lariat) left atrial appendage exclusion devices: Understanding the differences in the location and type of leaks and their clinical implications

Heart Rhythm

Volumn 12, Issue 7, 2015, Pages 1501-1507

  Pillarisetti, Jayasree ^a   Reddy, Yeruva Madhu ^a   Gunda, Sampath ^a   Swarup, Vijay ^b   Lee, Randall ^c   Rasekh, Abdi ^d   Horton, Rodney ^e   Massumi, Ali ^d   Cheng, Jie ^d,f   Bartus, Krzystzof ^g   Badhwar, Nitish ^c   Han, Frederick ^h   Atkins, Donita ^a   Bommana, Sudharani ^a   Earnest, Matthew ^a   Nath, Jayant ^a   Ferrell, Ryan ^a   Bormann, Steven ^a   Dawn, Buddhadeb ^a   Di Biase, Luigi ^e   Mansour, Moussa ⁱ   Natale, Andrea ^e   Lakkireddy, Dhanunjaya ^a   more..

^a UNIVERSITY OF KANSAS HOSPITAL   (United States)

^b Arizona Heart Rhythm Center   (United States)

^c UNIVERSITY OF SAN FRANCISCO   (United States)

^d TEXAS HEART INSTITUTE   (United States)

^e Texas Cardiac Arrhythmia Institute   (United States)

^f UNIVERSITY OF TEXAS   (United States)

^g Regional Centre for Diagnosis and Treatment of Viral Hepatitis and Hepatology   (Poland)

^h UNIVERSITY OF UTAH   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Efficacy; Exclusion; Lariat; Left atrial appendage; Safety; Watchman device

Indexed keywords

AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DEVICE EMBOLIZATION; FEMALE; HEART ATRIUM APPENDAGE; HEART LEFT ATRIUM; HEART TAMPONADE; HUMAN; LEFT ATRIAL APPENDAGE CLOSURE DEVICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; ADVERSE EFFECTS; ARTIFICIAL EMBOLIZATION; ATRIAL FIBRILLATION; CLINICAL TRIAL; COMPLICATION; DEVICE FAILURE ANALYSIS; DEVICES; INCIDENCE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROSTHESIS FAILURE; PROSTHETIC FITTING; SEPTAL OCCLUDER; STANDARDS; SURGERY; THROMBOEMBOLISM; TREATMENT OUTCOME; UNITED STATES;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; EQUIPMENT FAILURE ANALYSIS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; PROSTHESIS FAILURE; PROSTHESIS FITTING; SEPTAL OCCLUDER DEVICE; THERAPEUTIC OCCLUSION; THROMBOEMBOLISM; TREATMENT OUTCOME; UNITED STATES;

EID: 84937513502     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.03.020     Document Type: Article

References (35)

1. V.L. Roger, A.S. Go, D.M. Lloyd-Jones, and et al. Heart disease and stroke statistics - 2011 update: a report from the American Heart Association Circulation 123 2011 e18 e209
2. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, R.S. Vasan, R.B. D'Agostino, J.M. Massaro, A. Beiser, P.A. Wolf, and E.J. Benjamin Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
4. S. Bjorck, B. Palaszewski, L. Friberg, and L. Bergfeldt Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study Stroke 44 2013 3103 3108
5. M.F. Stoddard, P.R. Dawkins, C.R. Prince, and N.M. Ammash Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study J Am Coll Cardiol 25 1995 452 459
6. N.M. Al-Saady, O.A. Obel, and A.J. Camm Left atrial appendage: structure, function, and role in thromboembolism Heart 82 1999 547 554
7. E. Birman-Deych, M.J. Radford, D.S. Nilasena, and B.F. Gage Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation Stroke 37 2006 1070 1074
8. B.F. Gage, C. van Walraven, L. Pearce, R.G. Hart, P.J. Koudstaal, B.S. Boode, and P. Petersen Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin Circulation 110 2004 2287 2292
9. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, and et al. Dabigatran versus warfarin in patients with atrial fibrillation New Engl J Med 361 2009 1139 1151
10. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation New Engl J Med 365 2011 883 891
11. C.B. Granger, J.H. Alexander, J.J. McMurray, and et al. Apixaban versus warfarin in patients with atrial fibrillation New Engl J Med 365 2011 981 992
12. S. Apostolakis, D.A. Lane, H. Buller, and G.Y. Lip Comparison of the CHADS2, CHA2DS2-VASc and HAS-BLED scores for the prediction of clinically relevant bleeding in anticoagulated patients with atrial fibrillation: the AMADEUS trial Thrombosis Haemost 110 2013 1074 1079
13. D.R. Holmes Jr, D.R. Lakkireddy, R.P. Whitlock, R. Waksman, and M.J. Mack Left atrial appendage occlusion: opportunities and challenges J Am Coll Cardiol 63 2014 291 298
14. J.L. Blackshear, and J.A. Odell Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation Ann Thorac Surg 61 1996 755 759
15. J.L. Blackshear, W.D. Johnson, J.A. Odell, V.S. Baker, M. Howard, L. Pearce, C. Stone, D.L. Packer, and H.V. Schaff Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation J Am Coll Cardiol 42 2003 1249 1252
16. S.P. Salzberg, A. Plass, M.Y. Emmert, L. Desbiolles, H. Alkadhi, J. Grünenfelder, and M. Genoni Left atrial appendage clip occlusion: early clinical results J Thorac Cardiovasc Surg 139 2010 1269 1274
17. E.S. Katz, T. Tsiamtsiouris, R.M. Applebaum, A. Schwartzbard, P.A. Tunick, and I. Kronzon Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study J Am Coll Cardiol 36 2000 468 471
18. P.B. Sick, G. Schuler, K.E. Hauptmann, E. Grube, S. Yakubov, Z.G. Turi, G. Mishkel, S. Almany, and D.R. Holmes Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation J Am Coll Cardiol 49 2007 1490 1495
19. J.W. Park, A. Bethencourt, H. Sievert, G. Santoro, B. Meier, K. Walsh, J.R. Lopez-Minquez, D. Meerkin, M. Valdes, O. Ormerod, and B. Leithauser Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience Catheter Cardiovasc Interv 77 2011 700 706
20. K. Bartus, F.T. Han, J. Bednarek, J. Myc, B. Kapelak, J. Sadowski, J. Lelakowski, S. Bartus, S.J. Yakubov, and R.J. Lee Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience J Am Coll Cardiol 62 2013 108 118
21. D.R. Holmes, V.Y. Reddy, Z.G. Turi, S.K. Doshi, H. Sievert, M. Buchbinder, C.M. Mullin, and P. Sick PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial Lancet 374 2009 534 542
22. V.Y. Reddy, S. Mobius-Winkler, M.A. Miller, P. Neuzil, G. Schuler, J. Wiebe, P. Sick, and H. Sievert Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility Study With Watchman Left Atrial Appendage Closure Technology) J Am Coll Cardiol 61 2013 2551 2556
23. J.F. Viles-Gonzalez, S. Kar, P. Douglas, S. Dukkipati, T. Feldman, R. Horton, D. Holmes, and V.Y. Reddy The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy J Am Coll Cardiol 59 2012 923 929
24. M.S. Baker, J. Paul Mounsey, A.K. Gehi, and E.H. Chung Left atrial thrombus after appendage ligation with LARIAT Heart Rhythm 11 2014 1489
25. E. Giedrimas, A.C. Lin, and B.P. Knight Left atrial thrombus after appendage closure using LARIAT Circ Arrhythm Electrophysiol 6 2013 e52 e53
26. M.J. Price, D.N. Gibson, S.J. Yakubov, and et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium J Am Coll Cardiol 64 2014 565 572
27. M.A. Miller, S.R. Gangireddy, S.K. Doshi, A. Aryana, J.S. Koruth, S. Sennhauser, A. d'Avila, S.R. Dukkipati, P. Neuzil, and V.Y. Reddy Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device Heart Rhythm 11 2014 1853 1859
28. S.M. Singh, S.R. Dukkipati, A. d'Avila, S.K. Doshi, and V.Y. Reddy Percutaneous left atrial appendage closure with an epicardial suture ligation approach: a prospective randomized pre-clinical feasibility study Heart 7 2010 370 376
29. O. Kamp, P.M. Verhorst, R.C. Welling, and C.A. Visser Importance of left atrial appendage flow as a predictor of thromboembolic events in patients with atrial fibrillation Eur Heart J 20 1999 979 985
30. R. Mitusch, H.J. Siemens, M. Garbe, T. Wagner, A. Sheikhzadeh, and K.W. Diederich Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy Thromb Haemost 75 1996 219 223
31. K.R. Chun, S. Bordignon, V. Urban, L. Perrotta, D. Dugo, A. Fürnkranz, B. Nowak, and B. Schmidt Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience Heart Rhythm 10 2013 1792 1799
32. A.M. Pillai, A. Kanmanthareddy, M. Earnest, M. Reddy, R. Ferrell, J. Nath, J. Pillarisetti, A. Vallakati, and D. Lakkireddy Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application Heart Rhythm 11 2014 1877 1883
33. W.J. Mosley II, M.R. Smith, and M.J. Price Percutaneous management of late leak after Lariat transcatheter ligation of the left atrial appendage in patients with atrial fibrillation at high risk for stroke Catheter Cardiovasc Interv 83 2014 664 669
34. S.C. Lam, S. Bertog, and H. Sievert Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device) Catheter Cardiovasc Interv 85 2015 321 327
35. A. Massumi, M.G. Chelu, A. Nazeri, S.A. May, H. Afshar-Kharaghan, M. Saeed, M. Razavi, and A. Rasekh Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation Am J Cardiol 111 2013 869 873